Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Elicio Therapeutics Inc
(NQ:
ELTX
)
8.860
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
8.860
Bid (Size)
6.500 (1)
Ask (Size)
11.00 (2)
Prev. Close
8.860
Today's Range
8.860 - 8.860
52wk Range
2.960 - 24.39
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Thursday's Intraday Session
May 16, 2024
Via
Benzinga
ELTX Stock Earnings: Elicio Therapeutics Beats EPS for Q1 2024
May 15, 2024
ELTX stock results show that Elicio Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
+49.41%
+49.41%
1 Month
-9.03%
-9.03%
3 Month
+122.06%
+122.06%
6 Month
+59.35%
+59.35%
1 Year
-51.17%
-51.17%
More News
Read More
Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry
April 11, 2024
Via
News Direct
12 Health Care Stocks Moving In Friday's After-Market Session
April 05, 2024
Via
Benzinga
Unlocking the Power of Immunotherapy: Elicio Therapeutics’ (NASDAQ: ELTX) Novel AMP Platform
April 05, 2024
Via
News Direct
Topics
Death
Exposures
Death
First Patient Dosed In Phase 2 Study Of Elicio Therapeutics’ ELI-002 7P
February 01, 2024
Via
News Direct
ELTX Stock Earnings: Elicio Therapeutics Misses EPS for Q4 2023
April 02, 2024
Via
InvestorPlace
Benzinga's 2024 Virtual Healthcare: What's Next In Health?
March 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 07, 2024
Via
Benzinga
Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy
February 06, 2024
Via
News Direct
Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 05, 2024
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
Elicio Therapeutics Announces Publication Of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy
February 05, 2024
Via
Benzinga
First Patient Dosed In Phase 2 Study Of Elicio Therapeutics' ELI-002 7P
January 31, 2024
Via
Benzinga
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutics' AMPLIFY-201 Phase 1 Solid Tumor Study Of ELI-002
January 30, 2024
Via
News Direct
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutics' AMPLIFY-201 Phase 1 Solid Tumor Study Of ELI-002
January 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 29, 2024
Via
Benzinga
Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors
January 25, 2024
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 19, 2024
Via
Benzinga
Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium
January 17, 2024
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
